Literature DB >> 21988994

Glioma-related seizures: glutamate is the key.

Matthias Simon, Marec von Lehe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21988994     DOI: 10.1038/nm.2510

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults.

Authors:  Pierre A Robe; Didier H Martin; Minh T Nguyen-Khac; Maria Artesi; Manuel Deprez; Adelin Albert; Sophie Vanbelle; Stephane Califice; Markus Bredel; Vincent Bours
Journal:  BMC Cancer       Date:  2009-10-19       Impact factor: 4.430

Review 2.  Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.

Authors:  Wolfgang Löscher
Journal:  Seizure       Date:  2011-02-02       Impact factor: 3.184

3.  The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects.

Authors:  Cordelia Luyken; Ingmar Blümcke; Rolf Fimmers; Horst Urbach; Christian E Elger; Otmar D Wiestler; Johannes Schramm
Journal:  Epilepsia       Date:  2003-06       Impact factor: 5.864

4.  Inhibition of cystine uptake disrupts the growth of primary brain tumors.

Authors:  Wook Joon Chung; Susan A Lyons; Gina M Nelson; Hashir Hamza; Candece L Gladson; G Yancey Gillespie; Harald Sontheimer
Journal:  J Neurosci       Date:  2005-08-03       Impact factor: 6.167

5.  Insular gliomas: the case for surgical management.

Authors:  Matthias Simon; Georg Neuloh; Marec von Lehe; Bernhard Meyer; Johannes Schramm
Journal:  J Neurosurg       Date:  2009-04       Impact factor: 5.115

Review 6.  Brain tumors and epilepsy: pathophysiology of peritumoral changes.

Authors:  Mohammed F Shamji; Elana C Fric-Shamji; Brien G Benoit
Journal:  Neurosurg Rev       Date:  2009-02-11       Impact factor: 3.042

7.  Seizure characteristics and control following resection in 332 patients with low-grade gliomas.

Authors:  Edward F Chang; Matthew B Potts; G Evren Keles; Kathleen R Lamborn; Susan M Chang; Nicholas M Barbaro; Mitchel S Berger
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

8.  Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life.

Authors:  Martin Klein; Nadine H J Engelberts; Henk M van der Ploeg; Dorotheé G A Kasteleijn-Nolst Trenité; Neil K Aaronson; Martin J B Taphoorn; Hans Baaijen; W Peter Vandertop; Martin Muller; Tjeerd J Postma; Jan J Heimans
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

Review 9.  Seizures in patients with low-grade gliomas--incidence, pathogenesis, surgical management, and pharmacotherapy.

Authors:  D Kurzwelly; U Herrlinger; M Simon
Journal:  Adv Tech Stand Neurosurg       Date:  2010

10.  Glutamate release by primary brain tumors induces epileptic activity.

Authors:  Susan C Buckingham; Susan L Campbell; Brian R Haas; Vedrana Montana; Stefanie Robel; Toyin Ogunrinu; Harald Sontheimer
Journal:  Nat Med       Date:  2011-09-11       Impact factor: 53.440

View more
  4 in total

1.  A pathway map of glutamate metabolism.

Authors:  Soujanya D Yelamanchi; Savita Jayaram; Joji Kurian Thomas; Seetaramanjaneyulu Gundimeda; Aafaque Ahmad Khan; Anish Singhal; T S Keshava Prasad; Akhilesh Pandey; B L Somani; Harsha Gowda
Journal:  J Cell Commun Signal       Date:  2015-12-03       Impact factor: 5.782

2.  Targeting glia cells: novel perspectives for the treatment of neuropsychiatric diseases.

Authors:  B Di Benedetto; R Rupprecht
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

Review 3.  The Role of SLC7A11 in Cancer: Friend or Foe?

Authors:  Sijia Li; Zhenyao Lu; Runbin Sun; Suhan Guo; Fangfang Gao; Bei Cao; Jiye Aa
Journal:  Cancers (Basel)       Date:  2022-06-22       Impact factor: 6.575

4.  Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells.

Authors:  Michael C Oh; Joseph M Kim; Michael Safaee; Gurvinder Kaur; Matthew Z Sun; Rajwant Kaur; Anna Celli; Theodora M Mauro; Andrew T Parsa
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.